| Name | Title | Contact Details |
|---|
Eurofins Medinet is a Chantilly, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Horizon Blue Cross Blue Shield of New Jersey, the only licensed Blue Cross and Blue Shield plan in New Jersey, provides health insurance coverage to more than 3.6 million people throughout all of North, Central, and South Jersey. Horizon Blue Cross Blue Shield of New Jersey is best known for our managed care and traditional indemnity plans for individuals and employers — the cornerstone of our health care business. Horizon BCBSNJ traces its history back to 1932 when Associated Hospitals of Essex County, Inc. was formed as a multi-hospital prepayment plan. The company later became the nation`s first Blue Cross Plan. Horizon Blue Cross Blue Shield of New Jersey, is a not-for-profit, health service corporation. A 15-member Board of Directors governs the company for its members. There are no shareholders.
Anthelio Healthcare Solutions Inc. is much more than a healthcare IT company. We are a single source provider of world-class technology solutions for the healthcare industry with a 15-year history of excellence. Our innovative services and products make it easier for our customers to do what they do best – deliver outstanding patient care. Our company was built on the foundation that healthcare is our only business, uniquely positioning us as one of the very few companies who focus solely on the needs of our healthcare customers and their patients. We take great pride in maintaining the highest levels of client satisfaction for the hundreds of U.S. hospitals and healthcare providers we serve. We strive to provide a unique customer experience by proactively anticipating our customers' needs and pain points and by delivering fast, flexible and bold solutions. In an ever-evolving healthcare industry, we are at the forefront of delivering cutting-edge, scalable technologies and solutions that respond to the market's needs while maintaining sustainable value to our customers.
Dallas Endoscopy Center is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.